An OTIS/MotherToBaby Pregnancy Registry-based observational cohort study to evaluate pregnancy and infant outcomes in individuals exposed to Boostrix as of the 1st day of the 27th week of gestation in the US (EPI-PERTUSSIS-075 VS US PR 219588)

19/06/2023
23/05/2024
EU PAS number:
EUPAS105107
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol_Anonymized

English (1.49 MB - PDF) View document
Study results
Study report
Other information